These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7105642)

  • 1. [Therapeutic effect of a new molecule, epomediol, in intrahepatic cholestasis].
    Pasetti GC; De Simoni M; Giuberti T; Pedretti G; Pelosi G
    Clin Ter; 1982 May; 101(4):371-86. PubMed ID: 7105642
    [No Abstract]   [Full Text] [Related]  

  • 2. Epomediol ameliorates pruritus in patients with intrahepatic cholestasis of pregnancy.
    Gonzalez MC; Iglesias J; Tiribelli C; Ribalta J; Reyes H; Hernandez I; Bianchi M; Andrighetti F; Molina C
    J Hepatol; 1992 Sep; 16(1-2):241-2. PubMed ID: 1484159
    [No Abstract]   [Full Text] [Related]  

  • 3. [Epomediol-induced modifications of the biohumoral picture in hepatic cirrhosis with or without cholestasis].
    Alberti A; Andreuzzi B; Santese R; Rotondo F
    Clin Ter; 1983 Feb; 104(3):227-33. PubMed ID: 6345051
    [No Abstract]   [Full Text] [Related]  

  • 4. [Symptomatic effect of epomediol in patients with cholestasis of pregnancy].
    González M; Iglesias J; Tiribelli C; Ribalta J; Reyes H; Hernández I; Bianchi M; Andrighetti F; Molina C
    Rev Med Chil; 1992 May; 120(5):545-51. PubMed ID: 1343068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antilipemic activity of epomediol in patients with primary hyperlipidemia].
    Saba P; Galeone F; Natali A; Scalabrino A; Giuntoli F; Brunelleschi G
    Clin Ter; 1987 Jan; 120(1):37-43. PubMed ID: 2973855
    [No Abstract]   [Full Text] [Related]  

  • 6. [Efficacy and tolerance of intravenously administered epomediol in patients with hepatopathy].
    Fiocchi G; Dieci MG; Fiorani F; Galvani V; Lissandrin MR; Martino P; Politi E; Sotti A; Carrara GC
    Clin Ter; 1988 Oct; 127(1):37-41. PubMed ID: 2976340
    [No Abstract]   [Full Text] [Related]  

  • 7. [Epomediol treatment of fatty liver in alcohol abuse. A controlled clinical double-blind study].
    Pierri G; Giorgio A; Amoroso P; Fico P; Finelli L
    Clin Ter; 1985 Mar; 112(6):527-35. PubMed ID: 3893863
    [No Abstract]   [Full Text] [Related]  

  • 8. Activity of epomediol in the treatment of hepatopathies: a double-blind multi-centre study.
    Capurso L; Kock M; Ferrario F; Del Sette F; Gramolini C; Castiglioni CL
    J Int Med Res; 1987; 15(3):134-47. PubMed ID: 3301453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of epomediol on ethinyloestradiol-induced changes in bile acid and cholesterol metabolism in rats.
    Cuevas MJ; Mauriz JL; Almar M; Collado PS; González-Gallego J
    Clin Exp Pharmacol Physiol; 2001 Aug; 28(8):637-42. PubMed ID: 11473529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of epomediol on bile flow and composition in normal rats and in rats with ethynylestradiol-induced cholestasis.
    Zuin M; Dioguardi ML; Festorazzi S; Podda M
    Farmaco Prat; 1981 Aug; 36(8):383-9. PubMed ID: 7274418
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of ursodeoxycholic acid on chronic intrahepatic cholestasis due to sarcoidosis.
    Bécheur H; Dall'osto H; Chatellier G; Charton-Bain MC; Aubertin JM; Attar A; Bloch F; Petite JP
    Dig Dis Sci; 1997 Apr; 42(4):789-91. PubMed ID: 9125650
    [No Abstract]   [Full Text] [Related]  

  • 12. [Intrahepatic cholestasis of pregnancy. New treatment].
    Ranek L; Ott P
    Ugeskr Laeger; 1999 Sep; 161(39):5411-2. PubMed ID: 10553352
    [No Abstract]   [Full Text] [Related]  

  • 13. Biotransformation of epomediol. II - Urinary metabolites in the rat, dog and man.
    Ventura P; Pria R
    Farmaco Prat; 1982 Sep; 37(9):289-95. PubMed ID: 7140944
    [No Abstract]   [Full Text] [Related]  

  • 14. [Plasmatic clearance of antipyrine after treatment with epomediol].
    Del Vecchio S; Delle Monache M; Basoli A; Munoz ME; Alessandrini A; Ventura P; Schiavi M; Ricci GL
    Medicina (Firenze); 1988; 8(4):446-8. PubMed ID: 3244305
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of epomediol on the recovery time of taurocholic acid captation in the perfused rat liver after suspension of the treatment with ethynylestradiol.
    Chiarantini E; Chieca R; Orlandini F; Romeo D; Buzzelli G; Gentilini P
    Farmaco Prat; 1986 Nov; 41(11):358-62. PubMed ID: 3803561
    [No Abstract]   [Full Text] [Related]  

  • 16. Recurrent intrahepatic cholestasis of pregnancy: ursodeoxycholic acid should be the first line of treatment.
    Jain P
    J Gastrointestin Liver Dis; 2008 Dec; 17(4):479-80. PubMed ID: 19104716
    [No Abstract]   [Full Text] [Related]  

  • 17. Pregnancy course in patients with intrahepatic cholestasis of pregnancy treated with very low doses of ursodeoxycholic acid.
    Marschall HU
    Scand J Gastroenterol; 2016; 51(2):256. PubMed ID: 26315148
    [No Abstract]   [Full Text] [Related]  

  • 18. Action of acute ethanol intake on rat biliary secretion: effect of epomediol.
    Chiarantini E; Mazzanti R; Buzzelli G; Chieca R; Coletta D; Orlandini F; Romeo D; Arena U
    Farmaco Prat; 1986 Sep; 41(9):307-12. PubMed ID: 3770160
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cholestatic liver diseases].
    Reichel C; Meier-Abt PJ
    Ther Umsch; 1997 Nov; 54(11):639-44. PubMed ID: 9454366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Autoimmune cholestasis syndrome. Ursodeoxycholic acid is the drug standard].
    Stiefelhagen P
    MMW Fortschr Med; 2007 May; 149(21):49. PubMed ID: 17668736
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.